COMMUNIQUÉS West-GlobeNewswire

Intensity Therapeutics Highlights INT230-6 Data in Advanced Solid Tumors at Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting
08/11/2018
Intratumoral injections of INT230-6 were well tolerated with no drug-related serious adverse events or dose-limiting toxicity in Phase 1/2 clinical study Preclinical research demonstrates drug dispersion benefit of [...]
Conatus Pharmaceuticals Announces Presentations and Posters at AASLD Annual Meeting
08/11/2018
SAN DIEGO, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (NASDAQ: CNAT) announced today the schedule of upcoming oral presentations and posters addressing clinical and preclinical results with the [...]
Ovid Therapeutics Reports Third Quarter 2018 Financial Results and Highlights Recent Clinical Progress
08/11/2018
OV101 in Angelman syndrome: Plan to meet with U.S. FDA in the fourth quarter of 2018 to review Phase 2 STARS results and discuss next steps for program OV935/TAK-935 in rare developmental and epileptic encephalopathies [...]
Progenics Pharmaceuticals Announces Third Quarter 2018 Financial Results And Business Update
08/11/2018
AZEDRA ® (iobenguane I 131) Approved by U.S. Food and Drug Administration (FDA) AZEDRA U.S. Launch Progressing and AZEDRA Added to the NCCN Guidelines and Four CMS-Recognized Drug Compendia Phase 3 Study of PyL TM for [...]
Kura Oncology Adds Commercial Veteran Mary Szela to Board of Directors
08/11/2018
Ms. Szela brings expertise in global brand development to Kura as company enters first registration-directed trial SAN DIEGO, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage [...]
Specific Billing J-Code Issued for Trogarzo® by Center for Medicare and Medicaid Services
08/11/2018
MONTREAL, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that Trogarzo ® (ibalizumab-uiyk) injection has been assigned a specific J-Code. The new code will [...]
Trogarzo(MD) obtient un code de facturation « J » spécifique du Centre for Medicare and Medicaid Services
08/11/2018
MONTRÉAL, 08 nov. 2018 (GLOBE NEWSWIRE) -- Theratechnologies inc. (Theratechnologies) (TSX: TH) est heureuse d’annoncer qu’un code de facturation « J » spécifique a été assigné à Trogarzo MD (ibalizumab-uiyk) injection [...]
Moleculin Announces New Independent Study Expands Potential Use of Its Pancreatic Drug Candidate WP1122
08/11/2018
Documented potential for drug candidate with characteristics like WP1122 to reverse immune suppression HOUSTON, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a [...]
Clinical Results for BeyondSpring’s Lead Asset, Plinabulin for the Prevention of Chemotherapy-Induced Neutropenia, Demonstrated Superior Immune Profile Compared to Neulasta®
08/11/2018
Company to Present Latest Findings at 2018 Society for Immunotherapy of Cancer’s (SITC) Annual Meeting NEW YORK, Nov. 08, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc . (NASDAQ: BYSI), a global biopharmaceutical company [...]
Meridian Bioscience Reports Fourth Quarter and Full-Year Operating Results, Sets Fiscal 2019 Cash Dividend Rate, and Provides Fiscal 2019 Guidance
08/11/2018
CINCINNATI, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the fourth quarter and fiscal year ended September 30, 2018. Business Highlights: Completed [...]
Orchard Therapeutics Strengthens Global Commercial Leadership Team with Appointments of Heads of US and EMEA Region Commercial Operations
08/11/2018
Commercial team preparing for potential gene therapy launches BOSTON and LONDON, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Orchard Therapeutics, a leading commercial-stage biotech company dedicated to transforming the lives of [...]
THC Therapeutics Announces The US Patent office is granting a patent for their Cannabis Dryer
08/11/2018
The dHydronator ® is a Sanitizing Cannabis/Herb Sanitizing Dryer LAS VEGAS, Nov. 08, 2018 (GLOBE NEWSWIRE) -- THC Therapeutics Inc (OTC: MBLC) is a forward-thinking publicly traded Health and Wellness company in the [...]
resTORbio Co-Founder and Chief Medical Officer Joan Mannick, M.D., to Present on TORC1 Inhibition at The Gerontological Society of America 2018 Annual Scientific Meeting
08/11/2018
BOSTON, Nov. 08, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (Nasdaq: TORC), a clinical-stage biopharmaceutical company focused on helping people live healthier longer through the development and commercialization of novel [...]
ExCellThera announces clinical trial results using ECT-001 to be presented at ASH 2018 annual meeting
08/11/2018
MONTREAL, Nov. 08, 2018 (GLOBE NEWSWIRE) -- ExCellThera Inc., a biotechnology company delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use, today announced that results [...]
Resonant Inc. to Present at the Craig-Hallum 9th Annual Alpha Select Conference
08/11/2018
GOLETA, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio frequency, or RF, front-ends are being designed and delivered for wireless devices, is scheduled to [...]
Active Biotech: New data from the Phase 2 LEGATO-HD study will be presented at HSG 2018
08/11/2018
PRESS RELEASE New data from the Phase 2 LEGATO-HD study of laquinimod in Huntington's disease will be presented at the scientific conference HSG 2018 Lund Sweden, November 8, 2018 - Active Biotech (NASDAQ STOCKHOLM: [...]
Auris Medical to Report Third Quarter 2018 Financial Results and Provide Business Update on Thursday, November 15, 2018
08/11/2018
Zug, Switzerland, November 08, 2018 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and mental health [...]
Pluristem Therapeutics Reports Fiscal 2019 First Quarter Results and Provides Corporate Update
08/11/2018
HAIFA, Israel, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative medicine company developing novel placenta-based cell therapy products, today reported [...]
T2 Biosystems to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum
08/11/2018
LEXINGTON, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, [...]

Pages